Latest Shareholder Engagement News

WAM Global Limited has updated its special fully franked dividend and clarified the Dividend Reinvestment Plan price for the six months ending December 2024, offering investors a clear view on income and reinvestment options.

ikeGPS Limited has completed a significant placement of ordinary shares, issuing over 22 million new shares at NZD 0.88 each, representing nearly 14% of its total shares post-issue. The placement prioritized existing shareholders and aims to strengthen the company’s share register.

Macarthur Minerals has extended the timetable for its A$2 million renounceable rights issue, providing shareholders additional time to participate amid ongoing regulatory scrutiny by ASIC. The company confirms no changes to the offer terms and expects to lodge an updated Supplementary Prospectus shortly.

Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.

Carnarvon Energy is set to acquire up to a 19.9% stake in Strike Energy through an $89 million investment, positioning itself to benefit from Strike’s expanding gas portfolio in Western Australia.

Genmin Limited has raised an additional A$1 million in unsecured loans from key board members to support working capital for its flagship Baniaka iron ore project in Gabon.

Dundas Minerals has secured a substantial 612 square kilometre tenement package in the underexplored Gerry Well greenstone belt, positioning itself as a key gold explorer in Western Australia’s northern goldfields.

Openn Negotiation Ltd moves forward with a creditor-approved recapitalisation plan following voluntary administration, while its shares remain suspended on the ASX.

DP World Australia has secured Foreign Investment Review Board approval to acquire 100% of Silk Logistics, clearing a major regulatory hurdle for the deal.

Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.

Macarthur Minerals Limited has updated the timetable for its A$2 million renounceable rights issue, allowing shareholders more time to participate. The company also clarified an earlier announcement, confirming its agreement with Gold Valley Yilgarn Pty Ltd pertains only to the Lake Giles Hematite Project, not the Moonshine Magnetite Project.

Bass Oil Limited reported a 4% rise in June oil production alongside advancing plans to acquire the Vanessa gas field, signaling a strategic pivot towards gas sales and resource expansion.